Member Info for missthepenny62

Anyone with L2, just look at the way this is being manipulated the last couple of days. I despise the MMs and their dark arts on AIM. Right now for Tek, the buys massively outweigh the sells, but every time there is a sell they drop the SP to that price, then it takes a large number of buys to move it back up, then there's another sell and they drop it again. A law unto themselves.

This is why we need actual revenue, it's the only thing that can force the MMs to show a fairer price otherwise it becomes too obvious. Today's Lucyd news at least POINTS to new revenue, and certainly warranted a much bigger jump in price than has been 'permitted' so far.

GLA.

They own almost 100%. The Salarius CEO, an extremely capable guy with a huge rep, has a slice too, which can only be a good thing.

In fact Tek have been very good at attracting top people to work in their various companies for very little initial reward, so they all have skin in the game and wouldn't have joined if they weren't sold on the futures of the various projects. Guident is a good example of this - Tek just tweeted a 'chart' of their team there now and it's very impressive.

Cliff stated before that they needed two things for each project: A great idea, and great people to bring it to reality. VERY exciting couple of years ahead for this portfolio company IMO. I've been holding for about 3 years already and am now holding onto my shares tighter than ever.

I think the shake worked to scare a few away too. I've learned from bitter experience never to sell or buy based on price action.

From what I've seen, MMs have been known to drop a share price before good news to trigger stops and spook retail, and also spike a share before bad news to help some get out beforehand.

Two things about that: aim is the wild west and needs more regulating, and PIs should have a strictly long term strategy if they plan to be a long term holder.

Having said all that, the only thing that can really sustain a solid rise in SP nowadays is actual monetisation. After years of building up to it, Tek appears to be on the cusp of achieving this via Belluscura and Salarius, which should run into tens of millions or more in the next few years.

Obviously Belluscura approval isn't 100% guaranteed, but at this market cap I believe the current risk reward ratio makes it well worth holding here and Salarius mitigates any potential funding issues in other areas of the company's investment portfolio.

Having said that, the core business has shown steady growth, Lucyd should actually be profitable soonish and Guident IP is becoming more valuable by the day given the current situation.

AIMHO. GLA.

Absolutely spot on Wonder, and with the MMs dragging the bid down while keeping it NT to buy on a massive spread, they're shaking the tree before news as usual.

If they do get approval, which they really should all things considered, and when you count in Salarius, my long term target will move to pounds not pennies.

As for the price action; "It's a trap!" as Admiral Akbar would say...

GLA, not long now!

Black swan lack of demand is resulting in:

US shale being bankrupted, rigs and well being permanently shut down around the world, exploration being abandoned, OPEC+ cooperating to make cuts like never before, many oil companies going bust, and so on.

Once demand returns after lockdown, oil could well become more expensive than before this crisis began.

If RBD can time their divestment of WN right, today's SP is truly a unique opportunity.

Agreed. Two pre existing conditions that have been major issues with covid are high blood pressure and heart disease. The main cause of these among 'the masses' is a high sodium diet.

Mexico is just the beginning, I can see most govts enforcing sodium limits or at least insisting on food manufacturers giving high sodium warnings on their labeling.

Let's all hope for Belluscura device approval. If they get rejected I'd question the FDA's motives more than the company!!!

GLA.

Oil will recover. The record cuts are showing a newfound unity and realism among OPEC+. But more importantly the price crash now is closing many rigs and wells around the world, quite a few of them permanently - in particular US shale which has been holding the price down the past few years.

Once demand starts to recover as lockdowns end, oil could rebound hard.

And then, with Reabold owning the lion's share of up to $1bn in the ground (and UK onshore as an added bonus!), if S&S time the divestment right they could really deliver phenomenal returns for shareholders.

Some worried this is now a binary play but Parta will be progressed too and that is a large proven resource in its own right which could become a beast.

It's just Cali where the dynamic duo dropped the ball a bit despite all the 'running room' there, but they will learn from that. Reabold is still the best AIM oil play out there (perhaps along w UOG?), especially at the current SP! All IMHO of course.

DYOR.

For anyone here thinking of taking a bit of profit now instead of holding for gold, I just want to quote a few key lines from the company's most recent RNS:

"Avacta is already generating Affimer reagents that detect the COVID-19 virus and together with Cytiva will develop and manufacture a test capable of diagnosing the infection in minutes using a respiratory sample such as saliva."

Please note the words ALREADY and WILL before you sell.

We are literally just a few weeks away from Avactar and Cytiva bringing THE Covid test to the worldwide market. Think about it.

DYOR.

I think Belluscura attracted many here recently (which is fair enough!) and that's brought more attention to the incredible potential of Salarius, which has a great team heading it.

In simple terms, salt with the same taste but half the sodium is an absolute no brainer and I can see it being used in just about everything.

Add the fact that govts like Mexico are finally starting to issue guidance on high sodium consumption due to the devastating health effects, and it makes Tek shares potentially a life changing investment at this price.

This is no binary pharma play. The microsalt is already being made to order and there's plenty of interest. Once some snack / fast food companies start offering it, their competitors will want / need it to.

Same flavour crisps or fries but with half the sodium is an absolutely obvious choice that only the most ignorant of customers would ignore.

Even if this share hits 50p I will be loathe to sell more than a small slice, given the future value of Salarius compared to Tek's mkt cap.

Tek own 97% of the co and the CEO (who I've swapped a few emails with, a very cool and capable guy in his own right) holds the rest.

Not ramping, this is just the way I see it. Have been holding a long time but now it looks like patience is about to start paying off.

Tek previously stated their plan to divest their other IP (and pay a special div when it happens) but the microsalt appears to be one they want to keep hold of because they see the immense value long term.

DYOR.

thought the first message was lost. the second one is a bit more thought out but still probably no more informative as it's all guesswork right now!

To be fair, this is holding up surprisingly well. After that RNS I assumed every chaser would've been spooked and it crash through the floor.

Maybe there was more to the rise than just a ramp? Hard to tell cos the RNS was still pretty horrible.

I guess it's a case of more likely to fail than anything else, but the rewards of an RTO would be truly massive from this mcap so worth the risk for some. Hard to be objective having had an average holding of 40p!!!

Keep hearing about £100m in tax credits from all the R&D costs they peed up the wall. Iclaprim doesn't sound like a goer, so probably the RTO is the hope.

If that doesn't happen, let's see if lumsden can stop being a shamelessly greedy sc*mbag for once and help the co last until it's cash shell time. Having seen the problems ICON had after taking the WDC cash shell (hidden debts were run up by yet another lifestyle CEO), maybe the Motif shell would be a better deal for anyone looking to IPO as opposed to a brand new listing..? I would assume it'd be a pharma proposition given the state of the world, the markets right now, and the research tax credits. But then wdik

Just a few thoughts. Am supposed to be working so am rambling on here instead!

GLA.

To be fair, this is holding up surprisingly well. After that RNS I assumed every chaser would've been spooked and it crash through the floor.

Maybe there was more to the rise than just a ramp? Hard to tell cos the RNS was still pretty horrible.

I guess it's a case of more likely to fail than anything else, but the rewards of an RTO would be truly massive from this mcap so worth the risk for some. Hard to be objective having had an average holding of 42p!!!

Keep hearing about 100ml in tax credits from all the R&D peed up the wall. Iclaprim doesn't sound like a goer, but the RTO is the hope. Let's see if lumsden can stop being a shamelessly greedy sc*mbag and help the co last until it's cash shell time. Having seen the problems ICON had after taking the WDC cash shell (hidden debts run up by another lifestyle CEO), maybe the Motif shell would be a great deal for anyone looking to IPO? I would assume it'd be a pharma proposition given the state of the world and the markets right now.

Just a few thoughts. Am supposed to be working so am rambling on here instead!

GLA.

Am amazed at how some are still trying to ramp this (obviously bought the spike and trying to get out) after that RNS.

Not only did it state there's nothing behind the rise, they also go the begging bowl out as they have done with every single RNS since the day of the CRL which ruined so many people.

An sitting on a huge loss here myself but still don't want to see yet more PIs taken for a ride by lumsdens clapped out gravy train.

The guy should return his salary to help the company reach the shell stage. Has to be the biggest charlatan on AIM and wow that's saying something!

Be careful out there...

'ceased all operations' but will spend £250k in within the next month - WHO IS STILL TAKING A HUGE SALARY FOR THIS SHAREHOLDER MASSACRE?!?!?!?!?

Don't forget their core business which covers over half of all costs and is growing. It also gives them first dibs on every bright idea to come out of the world's leading tech research Uni's. They found Salarius that way and it cost them peanuts!

Conservative initial price tgt for me is 25p, although if it FDA approve / reject it'll hit 50 or 5 instantly anyway. Odds on it's the former but keeping fingers crossed in case!

GLA.

Agreed cliff. Lumsden has blood on his hands and i seriously wonder how he can ever look himself in the mirror again after this utter disaster.

Genuinely depressing.

here's the relevant tweet:

https://twitter.com/cevatlon/status/1240551908902920192

never been many tweeting about Midatech. Would be nice if the company somehow became relevant to the fight against Covid. every quality specialist scientist on the planet needs to be joining the fight right now!

GLA

just averaged town a bit. i know the sky is falling but the world will still need oil and even in this sickening 'market' i believe this price to be cheap. will buy more if it sinks further.

there might not be a zombie apoloypse on the streets but there is one on the LSE.

GLA, there's more to life than money - but this is hard I know.

Redmile (15.5p) and Yesod (15p) both bid for it, but now RM have the upper hand as they made their move while Yesod were trying to lowball.

So yes, could push each other up, no point selling now as 15.5 pretty much nailed on as a minimum amount. Nice.

hope they hold out for 28.5p cos that's my soddin average! actually 17p was my sell tgt after everything that's gone on before so...

am assuming it'll gap up to 15p on opening.

the mkt is still tanking hard and the current SP is 5.5, so am gonna take the loss as a win in somehow :-P

GLA.